Sign Up to like & get
recommendations!
1
Published in 2018 at "Neuro-oncology"
DOI: 10.1093/neuonc/noy059.501
Abstract: BACKGROUND The MYC oncogenes contribute to more than 50% of all human cancers, but their therapeutic targeting has proven challenging. MYC/MYCN amplification in childhood medulloblastoma (MB) and neuroblastoma (NB) determine aggressive disease and high mortality,…
read more here.
Keywords:
medulloblastoma neuroblastoma;
myc mycn;
mycn amplified;
adaptation myc ... See more keywords